The (cost) effectiveness of a very low-energy diet intervention with the use of eHealth in patients with type 2 diabetes and obesity: study protocol for a randomised controlled non... by Geurts, Karlijn A. M., Ozcan, Behiye, van Hoek, Mandy, van de Laar, Roel, van Teeffelen, Jolande, van Rosmalen, Joost, van Rossum, Elisabeth F. C., Berk, Kirsten A.

Get full text

The Effect of Including eHealth in Dietary Interventions for Patients with Type 2 Diabetes with Overweight or Obesity: A Systematic Review by Geurts, Karlijn A. M, Woodcock-Nekeman, Sandra, Hummel, Mitchell, Dietvorst, Carmen A. W, van Rossum, Elisabeth F. C, Berk, Kirsten A

Get full text

The Effect of Sargassum fusiforme and Fucus vesiculosus on Continuous Glucose Levels in Overweight Patients with Type 2 Diabetes Mellitus: A Feasibility Randomized, Double-Blind, P... by Geurts, Karlijn A M, Meijer, Sjoerd, Roeters van Lennep, Jeanine E, Wang, Xi, Özcan, Behiye, Voortman, Gardi, Liu, Hongbing, Castro Cabezas, Manuel, Berk, Kirsten A, Mulder, Monique T

Get full text

The by Geurts, Karlijn A. M, Ozcan, Behiye, van Hoek, Mandy, van de Laar, Roel, van Teeffelen, Jolande, van Rosmalen, Joost, van Rossum, Elisabeth F. C, Berk, Kirsten A

Get full text

The by Geurts, Karlijn A. M, Ozcan, Behiye, van Hoek, Mandy, van de Laar, Roel, van Teeffelen, Jolande, van Rosmalen, Joost, van Rossum, Elisabeth F. C, Berk, Kirsten A

Get full text

Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial by Lammers, Senna W. M., Geurts, Sandra M. E., Hermans, Karlijn E. P. E., van Hellemond, Irene E. G., Swinkels, Astrid C. P., Smorenburg, Carolien H., van der Sangen, Maurice J. C., Kroep, Judith R., Honkoop, Aafke H., van den Berkmortel, Franchette W. P. J., de Roos, Wilfred K., Imholz, Alexander L. T., Vriens, Ingeborg J. H., Tjan-Heijnen, Vivianne C. G.

Get full text

The evolution of precision oncology: The ongoing impact of the Drug Rediscovery Protocol (DRUP) by Haj Mohammad, Soemeya F, Timmer, Hans J L, Zeverijn, Laurien J, Geurts, Birgit S, Spiekman, Ilse A C, Verkerk, Karlijn, Verbeek, Florentine A J, Verheul, Henk M W, Voest, Emile E, Gelderblom, Hans

Get full text

Safety, Efficacy, and Biomarker Analysis of Crizotinib in MET-Mutated Non-Small Cell Lung Cancer-Results from the Drug Rediscovery Protocol by Verkerk, Karlijn, van der Wel, Tijmen J W T, Zeverijn, Laurien J, Geurts, Birgit S, Spiekman, Ilse A C, de Wit, Gijs F, Roepman, Paul, Jansen, Anne M L, van der Noort, Vincent, Smit, Egbert F, Hoeben, Ann, Hendriks, Lizza E L, van den Heuvel, Michel M, Piet, Berber, Herder, Gerarda J M, Hashemi, Sayed M S, Gelderblom, Hans, Verheul, Henk M W, Voest, Emile E, de Langen, Adrianus J

Get full text

Trastuzumab plus pertuzumab for HER2-amplified advanced colorectal cancer: Results from the drug rediscovery protocol (DRUP) by Spiekman, Ilse A.C., Zeverijn, Laurien J., Geurts, Birgit S., Verkerk, Karlijn, Haj Mohammad, Soemeya F., van der Noort, Vincent, Roepman, Paul, de Leng, Wendy W.J., Jansen, Anne M.L., Gootjes, Elske C., de Groot, Derk-Jan A., Kerver, Emile D., van Voorthuizen, Theo, Roodhart, Jeanine M.L., Valkenburg-van Iersel, Liselot B.J., Gelderblom, Hans, Voest, Emile E., Verheul, Henk M.W.

Get full text

Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol by Verkerk, Karlijn, Geurts, Birgit S., Zeverijn, Laurien J., van der Noort, Vincent, Verheul, Henk M.W., Haanen, John B.A.G., van der Veldt, Astrid A.M., Eskens, Ferry A.L.M., Aarts, Maureen J.B., van Herpen, Carla M.L., Jalving, Mathilde, Gietema, Jourik A., Devriese, Lot A., Labots, Mariette, Barjesteh van Waalwijk van Doorn-Khosrovani, Sahar, Smit, Egbert F., Bloemendal, Haiko J.

Get full text